Companion Dog & Loneliness in Elderly Persons

Overview

Elderly may have problems to create personal connections or to have physical activities in their day- to – day life; loneliness and social isolation may increase fragility in this population. Companion dog presence favours social relations, affective feelings and physical exercises. On the other hand dog presence raises risk of falling and has a cost for its owner. This project seeks to assess positive impacts of companion dog presence in elderly living at home. This transdisciplinar study (general practionners, veterinarians, dog instructors, nurses, researchers) evaluates loneliness and social isolation between elderly with or without a companion dog at home. Objective:To Evaluate the link between companion dog presence and loneliness in elderly persons living at home Method: An Observational, multicentric, transversal, national, comparative study (elderly with companion dog vs elderly without a dog). 200 subjects needed

Full Title of Study: “Companion Dog Impact on Loneliness and Social Link in Elderly Persons (≥ 75 Years Old) Living at Home : a Comparative Transversal Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: January 2022

Interventions

  • Other: dog presence
    • This project seeks to assess positive impacts of companion dog presence in elderly living at home ; to assess loneliness and isolement between eldlery with a companion dog and without, at home

Arms, Groups and Cohorts

  • Elderly with a companion dog
    • elderly living at home with a dog consulting his family doctor
  • Elderly without a companion dog
    • elderly living at home without a dog consulting his family doctor

Clinical Trial Outcome Measures

Primary Measures

  • assessment of loneliness using Jong Gierveld scale (11items).
    • Time Frame: 5 to 10 days after inclusion visit
    • emotional dimension (6items) social dimension (5items)

Secondary Measures

  • social isolation
    • Time Frame: 5 to 10 days after inclusion visit
    • Social Network Index french version (http://dx.doi.org/10.13072/midss.464)

Participating in This Clinical Trial

Inclusion Criteria

  • person aged ≥ 75years old – living at home Exclusion Criteria:

  • bedridden person – person accompanied by any animal, other than a dog – EPHAD based (establishments providing care for the dependent elderly) – comprehension or reading difficulties in french affecting study participation and scales assessment – cognitive, mental ou psychic disorders – person under legal protection

Gender Eligibility: All

Minimum Age: 75 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assistance Publique – Hôpitaux de Paris
  • Collaborator
    • Fondation MUTAC
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • FLORENCE CANOUI-POITRINE, MD-PHD, Principal Investigator, APHP CHU HENRI MONDOR
  • Overall Contact(s)
    • FLORENCE CANOUI-POITRINE, MD-PHD, 0149813695, florence.canoui-poitrine@aphp.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.